## **What is fluorouracil injection?**
HCPCS J9190 is the J code for fluorouracil (5-FU) injection, 500 mg, one of the most widely used chemotherapy drugs for treating different types of cancer, including colon, breast, pancreas, and stomach cancers. This drug works by interfering with the growth of cancer cells, slowing or stopping their spread.
The code description specifies billing per 500 mg, whether supplied in a single-dose vial or a multi-dose vial. Healthcare providers typically administer fluorouracil by intravenous infusion over the course of a few weeks, sometimes in combination with other chemotherapy agents.
For patients, fluorouracil treatment may cause side effects such as nausea, vomiting, or diarrhea, which must be carefully monitored. To support medical necessity and ensure accurate reimbursement, providers should document the indication, dosage, and progress report in alignment with Medicare and health plan guidelines.
While J9190 covers the injectable form, it’s important to note that there are other forms of fluorouracil, such as topical solutions used for skin conditions, which are not billed with this code. Proper billing and documentation reduce the risk of errors, support claims review, and help ensure services are reimbursed correctly.
## **Documentation requirements**
Records should include:
- **Drug name**: Fluorouracil / 5-FU.
- **Dosage administered**: Total dose in milligrams and the calculated billed units (1 unit = 500 mg).
- **Route of administration**: Clearly specify whether given by IV bolus or IV infusion.
- I**nfusion details**: If administered via infusion, record start and stop times to validate time-based CPT infusion codes.
- **Diagnosis/indication**: Link the service to an appropriate ICD-10 cancer diagnosis code or other covered indication (e.g., colon, breast, stomach, or pancreatic cancer).
- **Physician order or treatment protocol**: Maintain a signed physician order or documentation referencing an approved chemotherapy protocol.
- **Drug source information**: When required by the payer, include the lot number and expiration date of the fluorouracil vial to confirm drug integrity.
## **Billing requirements**
When billing HCPCS code J9190, providers should follow these guidelines to ensure accurate claims and reimbursement:
- **Unit of service**: Report 1 unit for every 500 mg of fluorouracil administered. Example: If 1,000 mg is given, bill J9190 × 2 units.
- **Place of service**: Typically billed by hospitals, oncology clinics, or infusion centers.
- **Drug Wastage**: Medicare requires billing of discarded drug amounts using modifier JW (for single-use vials). If no wastage occurred, use modifier JZ.
- **Administration codes**: Always pair with the correct CPT/HCPCS chemotherapy administration code, such as 96413 (IV infusion) or 96409 (IV push).
- **Reimbursement**: Under Medicare Part B, reimbursement is based on ASP (Average Sales Price) + 6%. Private payer rates may differ.
- **Complete information**: Claims should include full medication details, dosage, and administration method. Providers are encouraged to use payer resources and policy manuals for verification.
## **Other relevant codes**
- **96409** – Chemotherapy administration, IV push, single or initial substance/drug.
- **96413** – Chemotherapy administration, IV infusion, up to 1 hour, single or initial substance/drug.
- **96415** – Chemotherapy administration, IV infusion, each additional hour.
- **J9206** – Injection, irinotecan hydrochloride, 20 mg.
Frequently asked questions
